These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16446121)

  • 21. Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures.
    Ramsay RE; Perucca E; Robbins J; Barrett JA; Spiegel K
    Epilepsia; 2009 Aug; 50(8):1891-8. PubMed ID: 19490035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term add-on pregabalin treatment in patients with partial-onset epilepsy: pooled analysis of open-label clinical trials.
    Uthman BM; Bazil CW; Beydoun A; Schulze-Bonhage A; Benabou R; Whalen E; Emir B; Griesing T; Leon T
    Epilepsia; 2010 Jun; 51(6):968-78. PubMed ID: 20345940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exposure-response analysis of pregabalin add-on treatment of patients with refractory partial seizures.
    Miller R; Frame B; Corrigan B; Burger P; Bockbrader H; Garofalo E; Lalonde R
    Clin Pharmacol Ther; 2003 Jun; 73(6):491-505. PubMed ID: 12811359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lyrica (pregabalin) in the treatment of focal refractory epilepsy in adults].
    Vlasov PN; Andreeva OV; Iakunina AV; Kalinin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):53-9. PubMed ID: 21311489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregabalin in patients with primary brain tumors and seizures: a preliminary observation.
    Novy J; Stupp R; Rossetti AO
    Clin Neurol Neurosurg; 2009 Feb; 111(2):171-3. PubMed ID: 18977587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.
    Huppertz HJ; Feuerstein TJ; Schulze-Bonhage A
    Epilepsia; 2001 Jun; 42(6):790-2. PubMed ID: 11422338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral pregabalin as an add-on treatment for status epilepticus.
    Novy J; Rossetti AO
    Epilepsia; 2010 Oct; 51(10):2207-10. PubMed ID: 20550551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice.
    Carreño M; Maestro I; Molins A; Donaire A; Falip M; Becerra JL; Castillo J
    Seizure; 2007 Dec; 16(8):709-12. PubMed ID: 17604654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vigabatrin in unsatisfactory controlled epilepsies. Swiss Vigabatrin Study Group.
    Russ W
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(2):55-9. PubMed ID: 7569836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico).
    Rivera-Castaño L; Leal-Cantu R; Abreu P; Guerrero M; Davila G
    Epilepsy Res; 2012 Jun; 100(1-2):74-9. PubMed ID: 22304935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures.
    Bockbrader HN; Burger P; Knapp L; Corrigan BW
    Epilepsia; 2011 Feb; 52(2):248-57. PubMed ID: 21269291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.
    Stephen LJ; Parker P; Kelly K; Wilson EA; Leach V; Brodie MJ
    Acta Neurol Scand; 2011 Aug; 124(2):142-5. PubMed ID: 21434875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological and psychiatric impact of add-on titration of pregabalin versus levetiracetam: a comparative short-term study.
    Ciesielski AS; Samson S; Steinhoff BJ
    Epilepsy Behav; 2006 Nov; 9(3):424-31. PubMed ID: 16949344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
    Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
    Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA; Dumas C; Ghirardi L
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is a fair comparison in head-to-head trials of antiepileptic drugs?
    French J
    Lancet Neurol; 2011 Oct; 10(10):866-7. PubMed ID: 21889409
    [No Abstract]   [Full Text] [Related]  

  • 39. Pregabalin: preliminary experience in intractable childhood epilepsy.
    Jan MM; Zuberi SA; Alsaihati BA
    Pediatr Neurol; 2009 May; 40(5):347-50. PubMed ID: 19380070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin: as adjunctive treatment of partial seizures.
    Warner G; Figgitt DP
    CNS Drugs; 2005; 19(3):265-72; discussion 273-4. PubMed ID: 15740180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.